Joseph Boyett, DO
Sports Medicine · Athens, ALNPI 1326199530
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.7%), travel and lodging and entertainment — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Prime Surgical, LLC at 33.3% of the total. Reporting peaked in 2024 at $2,398 and has fallen 91.6% since, to $202 in 2025. That places this record below the midpoint for sports medicine clinicians in AL, where the typical reported total is $4,051.
Across 61 payments — averaging $66.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Prime Surgical, LLC$1K
- Arthrex$1K
- Globus Medical$928
- Ferring Pharmaceuticals Inc.$124
- Johnson & Johnson$109
- Nevro Corp.$59
- plus $155 from 7 others
What the payments were for
- Travel & lodging$1,93648%
- Food & beverage$2,05551%
- Entertainment$611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Prime Surgical, LLC | 7 | $1,347 |
| Arthrex | 23 | $1,330 |
| Globus Medical(2 entities) | 18 | $928 |
| Ferring Pharmaceuticals Inc. | 1 | $124 |
| Johnson & Johnson | 2 | $109 |
| Nevro Corp. | 2 | $59 |
| Saluda Medical Americas, Inc. | 1 | $44 |
| Medical Device Business Services, Inc. | 2 | $33 |
| Bioventus LLC | 1 | $21 |
| Olympus America Inc. | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Trice Medical, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,051 in reported general payments places this provider in the 50th percentile of 108 sports medicine providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $8,792 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 320 | $1,947 |
| Ondansetron Hcl | 264 | $1,371 |
| Oxycodone Hcl | 234 | $1,021 |
| Methocarbamol | 145 | $946 |
| Diclofenac Sodium | 31 | $531 |
| Meloxicam | 212 | $520 |
| Methylprednisolone | 50 | $356 |
| Tramadol Hcl | 119 | $327 |
| Ibuprofen | 82 | $261 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 55 | $256 |
| Levofloxacin | 23 | $194 |
| Celecoxib | 15 | $166 |
| Gabapentin | 18 | $150 |
| Clindamycin Hcl | 12 | $142 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Athens
- James StanfordAthens$3K
- Edward CainBirmingham$12.7M
- Daniel MatthewsDaphne$190K
- Mark RogersBirmingham$94K
- Amit MomayaBirmingham$77K
- Matthew SmithGuntersville$73K
- Christoper GarrettBirmingham$58K
- Jonathan IsbellHoover$55K
- James McMurtrieHuntsville$54K
- Reaves CrabtreeBirmingham$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.